Method of sterilization

• US 6,506,339 B1
• Filed: 06/03/1999
• Issued: 01/14/2003
• Est. Priority Date: 02/10/1997
• Status: Expired due to Term

• Current Assignee: Biomedical Design, Inc.
• Original Assignee: Biomedical Design, Inc.
• Inventors: Girardot, Marie-Nadia, Girardot, Jean-Marie
• Primary Examiner(s): McKane, Elizabeth
• Application Number:
  US09/325,511
• Time in Patent Office: 1,321 Days
• Field of Search: 422/28, 435/1.1, 8 9/411, 8 9/433
• US Class Current: 422/28
• CPC Class Codes: A01N 2300/00 Combinations or mixtures of active ingredients covered by classes A01N27/00 - A01N65/48 with other active or formulation relevant ingredients, e.g. specific carrier materials or surfactants, covered by classes A01N25/00 - A01N65/48
• CPC Class Codes: A01N 31/02 Acyclic compounds
• CPC Class Codes: A01N 37/32 Cyclic imides of polybasic carboxylic acids or thio analogues thereof
• CPC Class Codes: A01N 41/04 Sulfonic acids; Derivatives thereof
• CPC Class Codes: A01N 47/40 the carbon atom having a double or triple bond to nitrogen, e.g. cyanates, cyanamides
• CPC Class Codes: A61L 2/0088 Liquid substances
• CPC Class Codes: A61L 2/18 Liquid substances or solutions comprising solids or dissolved gases

Abstract

Heart valves or other components for replacement of heart or other bodily organs and tissue prostheses or synthetic prosthetic materials are effectively sterilized by treatment with a carbodiimide coupling agent known to create amide linkages between amines and carboxylic acids. Such treatment has been shown to be bactericidal when carried out using an effective concentration of such a carbodiimide at a temperature of at least about 35° C. for a sufficient period of time, e.g. treatment for about 9 hours at a concentration of at least about 50 mM. The sterilization treatment preferably employs EDC as a water-soluble coupling agent. Such sterilization treatment of biological tissue that has previously been fixed by subjection to stabilizing cross-linking is preferably carried out in a buffered aqueous solution and leaves no residuals other than ones which are nontoxic and biocompatible; moreover, it does not affect the desirable characteristics of resistance to thermal denaturation and to digestion by proteolytic enzymes, which are a product of such prior fixing, and may actually increase the resistance of such fixed biological tissue to degeneration and calcification.

Claims

1. A process for sterilization of material, which process comprises treating such material with a solution containing an effective amount of a coupling agent capable of creating amide bonds and maintaining such treatment for a time and at a temperature which is sufficient to kill microorganisms carried by such material, which treating is effective to cause at least a log 6 reduction in spores and bacteria that may have a resistance to chemical sterilants as great as that of Bacillus subtilis.

2. The process for sterilization according to claim 1 wherein said treatment is carried out at a temperature of at least about 35°

C.

3. The process for sterilization according to claim 1 wherein said treatment is carried out at a temperature of between about 40°

and about 55°

C.

4. The process for sterilization according to claim 3 wherein said coupling agent is present in said solution at a concentration of at least about 15 mM.

5. The process for sterilization according to claim 1 wherein said coupling agent is a water-soluble carbodiimide and is present in an aqueous solution at a concentration of at least about 50 mM.

6. The process for sterilization according to claim 5 wherein said aqueous solution contains a buffer and has a pH of about 6 to 7.

7. The process for sterilization according to claim 5 wherein said treatment is carried out for at least about 9 hours at a temperature of at least about 40°

C.

8. The process for sterilization according to claim 1 wherein said solution is an aqueous solution and said coupling agent is EDC.

9. The process for sterilization according to claim 8 wherein EDC is present at a concentration of at least about 25 millimolar and said treatment is carried out for at least about 24 hours at a temperature of at least about 40°

C.

10. The process for sterilization according to claim 1 wherein said treatment is carried out at a temperature of about 35-40°

C. for a period of concentration-time units of at least about 450 millimole hours.

11. A process for sterilization of biological tissue that has been previously subjected to cross-linking to improve stability, which process comprises treating such biological tissue at a temperature of at least about 35°

C. with an aqueous solution containing a concentration of at least about 25 mM of a water-soluble carbodiimide coupling agent that is capable of creating amide bonds for a period of concentration-time units sufficient to effectively kill any bacteria and spores carried by such biological tissue.

12. The process for sterilization according to claim 11 wherein a period of at least about 450 millimole-hours is used.

13. The process for sterilization according to claim 12 wherein said solution contains a concentration of at least about 50 mM EDC and wherein said treatment is carried out at between 40°

C. and about 55°

C.

14. The process for sterilization according to claim 11 wherein a period of at least about 100 millimole-hours is used and wherein the temperature of said treatment is maintained at about at least 55°

C.

15. The process for sterilization according to claim 11 wherein said solution contains EDC as said water-soluble coupling agent at a concentration of at least about 35 mM.

16. A process for sterilization of biological material, which process comprises treating such material with an aqueous solution containing a concentration of at least about 50 mM of a water-soluble carbodiimide coupling agent capable of creating amide bonds, at a temperature of at least about 40°

C., and maintaining such treatment for a time which is sufficient for said coupling agent to effectively kill spores and bacteria that may be carried by such material.

17. The process for sterilization according to claim 16 wherein said treatment is carried out at a temperature of between about 40°

and about 55°

C.

18. The process for sterilization according to claim 16 wherein said aqueous solution is buffered to a pH of about 6 to 7.

19. The process for sterilization according to claim 16 wherein said coupling agent is EDC.